ABNCoV2
id:
abncov2-309-12026606
title:
ABNCoV2
text:
ABNCoV2 is a cVLP COVID-19 vaccine candidate developed by Expres2ion Biotechnologies and Adaptvac, outlicensed to Bavarian Nordic. On 9 August 2021, it was announced that the first round of trials of the vaccine had been finalized with good results among 45 test subjects.
brand slug:
wiki
category slug:
encyclopedia
description:
Vaccine candidate against COVID-19
original url:
https://en.wikipedia.org/wiki/ABNCoV2
date created:
date modified:
2023-08-24T14:16:46Z
main entity:
{"identifier":"Q108471697","url":"https://www.wikidata.org/entity/Q108471697"}
image:
{"content_url":"https://upload.wikimedia.org/wikipedia/commons/9/94/Coronavirus._SARS-CoV-2.png","width":2048,"height":2048}
fields total:
13
integrity:
15